Clinical, molecular, and genomic changes in response to a left ventricular assist device

Journal of the American College of Cardiology

Volumn 57, Issue 6, 2011, Pages 641-652

  Hall, Jennifer L ^a   Fermin, David R ^b   Birks, Emma J ^c   Barton, Paul J R ^d   Slaughter, Mark ^e   Eckman, Peter ^a   Baba, Hideo A ^f   Wohlschlaeger, Jeremias ^f   Miller, Leslie W ^g  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e University of Louisville School of Medicine   (United States)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

beta adrenergic; calcium; clinical trials; gene expression; integrins; microarray; miRNA; ventricular assist device

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MEDICAID; MEDICARE; MOLECULAR GENETICS; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; SURVIVAL;

EID: 79551528796     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.010     Document Type: Review

References (55)

1. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
2. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
3. J.K. Kirklin, D.C. Naftel, and R.L. Kormos Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants J Heart Lung Transplant 29 2010 1 10
4. L.W. Miller, F.D. Pagani, and S.D. Russell Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
5. M.S. Slaughter, J.G. Rogers, and C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
6. E.A. Rose, A.J. Moskowitz, and M. Packer The REMATCH trial: rationale, design, and end points Ann Thorac Surg 67 1999 723 730
7. K.W. Chaudhary, E.I. Rossman, and V. Piacentino III Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart J Am Coll Cardiol 44 2004 837 845
8. K. Dipla, J.A. Mattiello, V. Jeevanandam, S.R. Houser, and K.B. Margulies Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure Circulation 97 1998 2316 2322
9. J.D. Harding, V. Piacentino III, J.P. Gaughan, S.R. Houser, and K.B. Margulies Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure Circulation 104 2001 1241 1247
10. P.M. Heerdt, J.W. Holmes, and B. Cai Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure Circulation 102 2000 2713 2719
11. K.B. Margulies Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments J Card Fail 8 2002 S500 S505
12. S. Maybaum, D. Mancini, and S. Xydas Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group Circulation 115 2007 2497 2505
13. M.L. Ogletree-Hughes, L.B. Stull, W.E. Sweet, N.G. Smedira, P.M. McCarthy, and C.S. Moravec Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart Circulation 104 2001 881 886
14. A. Zafeiridis, V. Jeevanandam, S.R. Houser, and K.B. Margulies Regression of cellular hypertrophy after left ventricular assist device support Circulation 98 1998 656 662
15. S. Klotz, A. Barbone, and S. Reiken Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties J Am Coll Cardiol 45 2005 668 676
16. S. Klotz, A.H. Danser, and R.F. Foronjy The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure J Am Coll Cardiol 49 2007 1166 1174
17. E.J. Birks, P.D. Tansley, and J. Hardy Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884
18. J.L. Hall, E.J. Birks, and S. Grindle Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy Eur Heart J 28 2007 613 627
19. C.M. Terracciano, M.U. Koban, and G.K. Soppa The role of the cardiac Na+/Ca2+ exchanger in reverse remodeling: relevance for LVAD-recovery Ann N Y Acad Sci 1099 2007 349 360
20. G.G. Holz Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell Diabetes 53 2004 5 13
21. S. Seino, and T. Shibasaki PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis Physiol Rev 85 2005 1303 1342
22. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices Circ Res 91 2002 517 524
23. S.O. Marx, S. Reiken, and Y. Hisamatsu Pka phosphorylation dissociates fkbp12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 101 2000 365 376
24. C.M. Terracciano, S.E. Harding, and D. Adamson Changes in sarcolemmal ca entry and sarcoplasmic reticulum ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy Eur Heart J 24 2003 1329 1339
25. O.H. Frazier, and T.J. Myers Left ventricular assist system as a bridge to myocardial recovery Ann Thorac Surg 68 1999 734 741
26. C.M. Terracciano, J. Hardy, E.J. Birks, A. Khaghani, N.R. Banner, and M.H. Yacoub Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy Circulation 109 2004 2263 2265
27. M.L. Ogletree, W.E. Sweet, and C. Talerico Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart J Heart Lung Transplant 29 2010 554 561
28. B.E. Jaski, M.L. Jessup, and D.M. Mancini Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID trial), a first-in-human phase 1/2 clinical trial J Card Fail 15 2009 171 181
29. E.J. Birks, J.L. Hall, and P.J. Barton Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support Circulation 112 2005 I57 I64
30. J.A. Towbin, and N.E. Bowles The failing heart Nature 415 2002 227 233
31. E. Lara-Pezzi, C.M. Terracciano, and G.K. Soppa A gene expression profile of the myocardial response to clenbuterol J Cardiovasc Transl Res 2 2009 191 197
32. M.E. Cullen, A.H. Yuen, and L.E. Felkin Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis Circulation 114 2006 I16 I20
33. P.J. Barton, L.E. Felkin, and E.J. Birks Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy Circulation 112 2005 I46 I50
34. J.L. Hall, S. Grindle, and X. Han Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks Physiol Genomics 17 2004 283 291
35. P.K. Bhavsar, N.J. Brand, and L.E. Felkin Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1 J Cardiovasc Transl Res 3 2010 688 695
36. M.A. Saunders, H. Liang, and W.H. Li Human polymorphism at microRNAs and microRNA target sites Proc Natl Acad Sci U S A 104 2007 3300 3305 (Pubitemid 46364154)
37. L.P. Lim, M.E. Glasner, S. Yekta, C.B. Burge, and D.P. Bartel Vertebrate microRNA genes Science 299 2003 1540
38. S.J. Matkovich, D.J. Van Booven, and K.A. Youker Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support Circulation 119 2009 1263 1271
39. E. van Rooij, L.B. Sutherland, and N. Liu A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure Proc Natl Acad Sci U S A 103 2006 18255 18260
40. M. Tatsuguchi, H.Y. Seok, and T.E. Callis Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy J Mol Cell Cardiol 42 2007 1137 1141
41. M. Kuhn, M. Voss, and D. Mitko Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure Cardiovasc Res 64 2004 308 314
42. H. Tsuneyoshi, W. Oriyanhan, and H. Kanemitsu Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading? Circulation 112 2005 I51 I56
43. J. Wang, M. Tsukashita, and T. Nishina Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts J Thorac Cardiovasc Surg 137 2009 465 470
44. M. Pieroni, A. Corti, and B. Tota Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function Eur Heart J 28 2007 1117 1127
45. J. Wohlschlaeger, M. von Winterfeld, and H. Milting Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading J Heart Lung Transplant 27 2008 442 449
46. K.B. Margulies, S. Matiwala, C. Cornejo, H. Olsen, W.A. Craven, and D. Bednarik Mixed messages: transcription patterns in failing and recovering human myocardium Circ Res 96 2005 592 599
47. S.G. Drakos, A.G. Kfoury, and E.H. Hammond Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart J Am Coll Cardiol 56 2010 382 391
48. J.A. Hill, and E.N. Olson Cardiac plasticity N Engl J Med 358 2008 1370 1380
49. J. Herrmann, A. Ciechanover, L.O. Lerman, and A. Lerman The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended Cardiovasc Res 61 2004 11 21
50. S. Klotz, R.F. Foronjy, and M.L. Dickstein Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness Circulation 112 2005 364 374
51. B. Greenberg, M.A. Quinones, and C. Koilpillai Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD Echocardiography substudy Circulation 91 1995 2573 2581
52. C. van Krimpen, J.F. Smits, and J.P. Cleutjens DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril J Mol Cell Cardiol 23 1991 1245 1253
53. O. Lisy, M.M. Redfield, and S. Jovanovic Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function in vivo Circulation 102 2000 338 343
54. O. Lisy, M.M. Redfield, J.A. Schirger, and J.C. Burnett Jr Atrial BNP endocrine function during chronic unloading of the normal canine heart Am J Physiol Regul Integr Comp Physiol 288 2005 R158 R162
55. H.T. Tevaearai, G.B. Walton, A.D. Eckhart, J.R. Keys, and W.J. Koch Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts J Thorac Cardiovasc Surg 124 2002 1149 1156